Testing P2Y12 Platelet Inhibitors Generics Beyond Bioequivalence
NCT05474053
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
29
Enrollment
OTHER
Sponsor class
Conditions
Cardiovascular Diseases
Acute Coronary Syndrome
Interventions
DRUG:
Ticagrelor 90mg (Brilique)
DRUG:
Ticagrelor 90mg (Ticaloguard)
Sponsor
Cairo University